• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • The Congolese philosopher who liberated ‘Africa’ from the chains of Western thought
    • A new book examines the repercussions of shutting the Indian Railways network during Covid-19
    • Four questions Indians must ask about Operation Sindoor
    • Interview: US claiming credit for ceasefire sets Indian foreign policy back by decades
    • ‘A period of transformation’: Why Marathi film ‘April May 99’ couldn’t have been set in another year
    • Rush Hour: India denies US claims on trade threat, order blocking ‘4PM News’ lifted and more
    • The 2025 Pulitzer Prizes: A readers’ guide to the seven winning books
    • How to read blood cholesterol tests
    • In Manipur, Kuki-Zo women are protesting customary ‘settlement’ of rape, domestic violence cases
    • ‘The Royals’ review: All dressed up with nowhere to go
    • India declares Pakistan High Commission official persona non grata
    • Why the India-Pakistan ceasefire is giving Modi supporters heartburn
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

big pharma

  • Pharmaceutical sector: Why India needs a regulatory pathway for biosimilar drugs

    Pharmaceutical sector: Why India needs a regulatory pathway for biosimilar drugs

    Dinesh Thakur Prashant Reddy T
    · Mar 07, 2024 · 09:00 am
  • My brief exchange with John le Carré

    My brief exchange with John le Carré

    Dylan Mohan Gray
    · Dec 16, 2020 · 11:30 am
  • Pharmaceutical firms have quietly enlisted leading professors to justify expensive drugs

    Pharmaceutical firms have quietly enlisted leading professors to justify expensive drugs

    Annie Waldman, ProPublica
    · Feb 25, 2017 · 09:30 pm
  • Udta Amrika: A tale of two movies and two drug epidemics

    Udta Amrika: A tale of two movies and two drug epidemics

    Girish Shahane
    · Jun 15, 2016 · 12:30 pm
  • This Pune company is Asia's largest vaccine maker and says it has a cure for dengue

    This Pune company is Asia's largest vaccine maker and says it has a cure for dengue

    The Caravan
    · Sep 22, 2015 · 03:33 pm